Diagnostic-testing stocks slide after proposed cuts to Medicare payments for lab services

Shares of diagnostic-testing companies fell after a proposal to cut Medicare payments for laboratory services, according to a news report. The proposed reimbursement reduction would hit lab-test providers' revenue.

Detected & updated continuously · Source: Nebula